141 related articles for article (PubMed ID: 11127947)
1. Biodistribution of paclitaxel and poly(L-glutamic acid)-paclitaxel conjugate in mice with ovarian OCa-1 tumor.
Li C; Newman RA; Wu QP; Ke S; Chen W; Hutto T; Kan Z; Brannan MD; Charnsangavej C; Wallace S
Cancer Chemother Pharmacol; 2000; 46(5):416-22. PubMed ID: 11127947
[TBL] [Abstract][Full Text] [Related]
2. Renal targeting potential of a polymeric drug carrier, poly-l-glutamic acid, in normal and diabetic rats.
Chai HJ; Kiew LV; Chin Y; Norazit A; Mohd Noor S; Lo YL; Looi CY; Lau YS; Lim TM; Wong WF; Abdullah NA; Abdul Sattar MZ; Johns EJ; Chik Z; Chung LY
Int J Nanomedicine; 2017; 12():577-591. PubMed ID: 28144140
[TBL] [Abstract][Full Text] [Related]
3. Biological and clinical characterization of paclitaxel poliglumex (PPX, CT-2103), a macromolecular polymer-drug conjugate.
Chipman SD; Oldham FB; Pezzoni G; Singer JW
Int J Nanomedicine; 2006; 1(4):375-83. PubMed ID: 17722272
[TBL] [Abstract][Full Text] [Related]
4. Complete regression of well-established tumors using a novel water-soluble poly(L-glutamic acid)-paclitaxel conjugate.
Li C; Yu DF; Newman RA; Cabral F; Stephens LC; Hunter N; Milas L; Wallace S
Cancer Res; 1998 Jun; 58(11):2404-9. PubMed ID: 9622081
[TBL] [Abstract][Full Text] [Related]
5. Characteristics and effects of inflammation in end-stage renal disease.
Kaysen GA; Eiserich JP
Semin Dial; 2003; 16(6):438-46. PubMed ID: 14629602
[TBL] [Abstract][Full Text] [Related]
6. Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis.
Didier A; Malling HJ; Worm M; Horak F; Jäger S; Montagut A; André C; de Beaumont O; Melac M
J Allergy Clin Immunol; 2007 Dec; 120(6):1338-45. PubMed ID: 17935764
[TBL] [Abstract][Full Text] [Related]
7. Cost effectiveness analysis of immunotherapy in patients with grass pollen allergic rhinoconjunctivitis in Germany.
Westerhout KY; Verheggen BG; Schreder CH; Augustin M
J Med Econ; 2012; 15(5):906-17. PubMed ID: 22533527
[TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory effects of statins: clinical evidence and basic mechanisms.
Jain MK; Ridker PM
Nat Rev Drug Discov; 2005 Dec; 4(12):977-87. PubMed ID: 16341063
[TBL] [Abstract][Full Text] [Related]
9. St John's wort for major depression.
Linde K; Berner MM; Kriston L
Cochrane Database Syst Rev; 2008 Oct; 2008(4):CD000448. PubMed ID: 18843608
[TBL] [Abstract][Full Text] [Related]
10. Paclitaxel poliglumex (XYOTAX; CT-2103): an intracellularly targeted taxane.
Singer JW; Shaffer S; Baker B; Bernareggi A; Stromatt S; Nienstedt D; Besman M
Anticancer Drugs; 2005 Mar; 16(3):243-54. PubMed ID: 15711176
[TBL] [Abstract][Full Text] [Related]
11. Do statins have a role in the promotion of postoperative wound healing in cardiac surgical patients?
Fitzmaurice GJ; McWilliams B; Nölke L; Redmond JM; McGuinness JG; O'Donnell ME
Ann Thorac Surg; 2014 Aug; 98(2):756-64. PubMed ID: 24980602
[TBL] [Abstract][Full Text] [Related]
12. Sustained 3-year efficacy of pre- and coseasonal 5-grass-pollen sublingual immunotherapy tablets in patients with grass pollen-induced rhinoconjunctivitis.
Didier A; Worm M; Horak F; Sussman G; de Beaumont O; Le Gall M; Melac M; Malling HJ
J Allergy Clin Immunol; 2011 Sep; 128(3):559-66. PubMed ID: 21802126
[TBL] [Abstract][Full Text] [Related]
13. Wound macrophages as key regulators of repair: origin, phenotype, and function.
Brancato SK; Albina JE
Am J Pathol; 2011 Jan; 178(1):19-25. PubMed ID: 21224038
[TBL] [Abstract][Full Text] [Related]
14. Inflammation in end-stage renal disease: the hidden enemy.
Stenvinkel P
Nephrology (Carlton); 2006 Feb; 11(1):36-41. PubMed ID: 16509930
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel poliglumex (XYOTAX, CT-2103): a macromolecular taxane.
Singer JW
J Control Release; 2005 Dec; 109(1-3):120-6. PubMed ID: 16297482
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide synthase inhibition in sepsis? Lessons learned from large-animal studies.
Hauser B; Bracht H; Matejovic M; Radermacher P; Venkatesh B
Anesth Analg; 2005 Aug; 101(2):488-498. PubMed ID: 16037166
[TBL] [Abstract][Full Text] [Related]
17. Taxol (paclitaxel): mechanisms of action.
Horwitz SB
Ann Oncol; 1994; 5 Suppl 6():S3-6. PubMed ID: 7865431
[TBL] [Abstract][Full Text] [Related]
18. A potential wound-healing-promoting peptide from salamander skin.
Mu L; Tang J; Liu H; Shen C; Rong M; Zhang Z; Lai R
FASEB J; 2014 Sep; 28(9):3919-29. PubMed ID: 24868009
[TBL] [Abstract][Full Text] [Related]
19. A systematic review of duloxetine and venlafaxine in major depression, including unpublished data.
Schueler YB; Koesters M; Wieseler B; Grouven U; Kromp M; Kerekes MF; Kreis J; Kaiser T; Becker T; Weinmann S
Acta Psychiatr Scand; 2011 Apr; 123(4):247-65. PubMed ID: 20831742
[TBL] [Abstract][Full Text] [Related]
20. Cost effectiveness of representatives of three classes of antidepressants used in major depression in the UK.
Lenox-Smith A; Conway P; Knight C
Pharmacoeconomics; 2004; 22(5):311-9. PubMed ID: 15061681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
